Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2015

Oct 28, 2015

29875_dirs_2015-10-28_77f93cb3-32ae-4ae4-b490-46e772c5b5d5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2015-10-27

Reporting Person: Brennan Troyen A (EVP, Chief Medical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-10-27 Common Stock M 23603 $54.53 Acquired 85444.059 Direct
2015-10-27 Common Stock S 23603 $105.00 Disposed 61841.059 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-10-27 Stock Option $54.53 M 23603 Disposed 2020-04-01 Common Stock (23603) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock (restricted) 43858 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $45.07 2019-04-02 Common Stock (16637) 16637 Direct
Stock Option $74.29 2021-04-01 Common Stock (54550) 54550 Direct
Stock Option $102.26 2022-04-01 Common Stock (47937) 47937 Direct

Footnotes

F1: All sales were effected pursuant to a Rule 10b5-1 plan.

F2: Option became exercisable in four equal annual installments, commencing 4/1/2014.

F3: Option became exercisable in four equal annual installments, commencing 4/2/2013.

F4: Option became exercisable in four equal annual installments, commencing 4/1/2015.

F5: Option becomes exercisable in four equal annual installments, commencing 4/1/2016.